Dividend-screened portfolios of various kinds have failed to keep up with the broad US stock market over the past 10 years, ...

The S&P 500 advanced 0.92% to 6,067.70, with technology shares seeing the biggest gains among sectors. The Technology Select ...

Lasell University president Eric Turner is hoping that many Lasell students will find success in the real world by spending ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

AnalytiXIN has launched a consortium designed to give Indiana researchers better access to health care data—potentially ...

The suit names 21 defendants, including some of the biggest names in pharmaceuticals and insurance: Eli Lilly and Company ...

This week's stock market saw the S&P 500 rise 3.4%, fueled by positive inflation data and strong earnings reports.

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...

In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic response at one year ...

There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its ...

During a roughly five-year span, CVS Health, Cigna, and UnitedHealth benefited the most from increasing prices for generic drugs that treated illnesses such as HIV and cancer. Some of the price hikes ...